Therefore, the impact of ADAMTS13 levels and the presence of its inhibitors on overall survival, ultimate clinical outcome, responsiveness to plasma exchange, and relapse in pregnancy-related TTP are still controversial. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.